We are live on ! Find out more
NVCR icon

NovoCure

58 hedge funds and large institutions have $196M invested in NovoCure in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

119% more call options, than puts

Call options by funds: $3.03M | Put options by funds: $1.38M

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

23% more funds holding

Funds holding: 4758 (+11)

21% less capital invested

Capital invested by funds: $249M → $196M (-$52.9M)

Holders
58
Holders Change
+11
Holders Change %
+23.4%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
19
Increased
19
Reduced
14
Closed
8
Calls
$3.03M
Puts
$1.38M
Net Calls
+$1.65M
Net Calls Change
+$697K

NVCR Hedge Fund Activity: Q1 2016 in Review

58 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q1 2016, worth a combined $196M — down 21% from $249M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new NVCR positions and 8 closed out — a net gain of 11 holders — while 19 added to existing stakes and 14 trimmed.

The largest buyer was StepStone Group, opening a new position worth an estimated $26.1M. The largest seller was Alkeon Capital Management, cutting an estimated $2.56M.

  • 58 institutional investors held NovoCure (NVCR) as of Q1 2016, up from 47 in Q4 2015.
  • Funds reported $196M of NovoCure stock for Q1 2016, down 21% quarter-over-quarter.
  • 19 funds opened new NovoCure positions in Q1 2016 and 8 closed out, a net change of +11 holders.
  • The largest NovoCure buyer in Q1 2016 was StepStone Group, an estimated $26.1M added.
  • The largest NovoCure seller in Q1 2016 was Alkeon Capital Management, an estimated $2.56M sold.

Based on aggregated 13F filings for Q1 2016.